Accelerating Action to End Malaria: A Test of Africa’s Health Security and Sovereignty

As Africa marks World Malaria Day 2026, the continent faces a critical juncture in its fight against malaria. Despite significant progress over the past two decades, malaria remains a devastating burden, particularly for vulnerable populations. In 2024, Africa accounted for an estimated 270.8 million malaria cases and nearly 600,000 deaths, representing 96% of global cases and 97% of global malaria deaths. Children under five years of age and pregnant women continue to bear the heaviest toll of this preventable disease.

This article examines the current state of malaria in Africa, the progress made, emerging challenges, and the urgent need for sustained, innovative action to achieve elimination goals by 2030.

The Persistent Burden of Malaria in Africa

Malaria continues to impose one of the heaviest and most avoidable burdens on the African continent. The disease is not merely a health issue; it directly constrains Africa’s development by weakening human capital, reducing productivity, deepening poverty, and hindering progress toward Agenda 2063 and universal health coverage goals.

Despite the scale-up of proven interventions—insecticide-treated nets, indoor residual spraying, rapid diagnostic testing, artemisinin-based combination therapy, seasonal malaria chemoprevention, malaria vaccines, and stronger community-level delivery—millions of lives have been saved over the past two decades. Several African countries have achieved malaria-free certification, demonstrating that elimination is achievable with strong surveillance, targeted interventions, and sustained political commitment.

Progress and Emerging Challenges

Between 2000 and 2022, the WHO African Region experienced a 40% decrease in malaria incidence and a 60% reduction in mortality rate. But, recent epidemiological reports from Africa CDC indicate that progress has stalled and even reversed in some areas, with malaria incidence showing signs of resurgence.

Several interconnected challenges threaten to undermine hard-won gains:

• Climate change is altering mosquito breeding patterns and expanding transmission zones into previously unaffected areas.
• Poverty and weak health infrastructure limit access to prevention, diagnosis, and treatment services, particularly in rural and conflict-affected regions.
• The emergence of antimalarial drug resistance, including artemisinin partial resistance documented in several African settings, raises serious concerns for the long-term effectiveness of first-line treatments.
• Insecticide resistance in mosquito populations further complicates vector control efforts.
• Substandard health services and coverage gaps hinder timely diagnosis and treatment, increasing the risk of severe disease and death.

the proportion of asymptomatic or clinically atypical malaria cases has increased due to repeated infections and early interventions, complicating diagnosis and increasing the risk of undetected transmission.

The Path Forward: Sustained and Innovative Action

Malaria elimination by 2030 cannot be achieved through aspiration alone. It requires sustained, innovative actions grounded in leadership, implementation quality, accountability, and investment. Africa CDC is partnering with organizations like Medicines for Malaria Venture (MMV) to promote access to quality-assured antimalarial drugs and strengthen health systems.

Key strategies for accelerating progress include:

• Scaling up proven interventions while adapting to changing epidemiological contexts.
• Investing in research and development of new tools, including next-generation vaccines, drugs, and vector control technologies.
• Strengthening surveillance systems to detect and respond to outbreaks and resistance patterns rapidly.
• Ensuring equitable access to interventions for the most vulnerable populations, including children under five and pregnant women.
• Fostering regional cooperation and cross-border initiatives to address the transboundary nature of malaria transmission.
• Securing sustainable financing through domestic resource mobilization and continued international support.

The rollout of malaria vaccines across Africa represents a significant advancement in the fight against the disease. However, vaccine introduction must be integrated into comprehensive malaria control programs rather than viewed as a standalone solution.

Conclusion

The fight against malaria in Africa is at a pivotal moment. While the tools and knowledge to defeat malaria exist, success depends on translating political commitment into effective action on the ground. The resurgence of malaria cases and the emergence of drug resistance serve as urgent reminders that complacency is not an option.

By prioritizing malaria elimination as a cornerstone of health security and sovereignty, African nations can protect their most vulnerable citizens, strengthen health systems, and unlock the continent’s full development potential. The path to a malaria-free Africa by 2030 demands unwavering commitment, innovative strategies, and collective action from governments, health workers, communities, and global partners.

World Malaria Day 2026 serves as both a reminder of the work still ahead and an opportunity to renew the commitment to ending this preventable disease once and for all.

Accelerating Action to End Malaria: A Test of Africa’s Health Security and Sovereignty

As Africa marks World Malaria Day 2026, the continent faces a critical juncture in its fight against malaria. Despite significant progress over the past two decades, malaria remains a devastating burden, particularly for vulnerable populations. In 2024, Africa accounted for an estimated 270.8 million malaria cases and nearly 600,000 deaths, representing 96% of global cases and 97% of global malaria deaths. Children under five years of age and pregnant women continue to bear the heaviest toll of this preventable disease.

This article examines the current state of malaria in Africa, the progress made, emerging challenges, and the urgent need for sustained, innovative action to achieve elimination goals by 2030.

The Persistent Burden of Malaria in Africa

Malaria continues to impose one of the heaviest and most avoidable burdens on the African continent. The disease is not merely a health issue; it directly constrains Africa’s development by weakening human capital, reducing productivity, deepening poverty, and hindering progress toward Agenda 2063 and universal health coverage goals.

Despite the scale-up of proven interventions—insecticide-treated nets, indoor residual spraying, rapid diagnostic testing, artemisinin-based combination therapy, seasonal malaria chemoprevention, malaria vaccines, and stronger community-level delivery—millions of lives have been saved over the past two decades. Several African countries have achieved malaria-free certification, demonstrating that elimination is achievable with strong surveillance, targeted interventions, and sustained political commitment.

Progress and Emerging Challenges

Between 2000 and 2022, the WHO African Region experienced a 40% decrease in malaria incidence and a 60% reduction in mortality rate. However, recent epidemiological reports from Africa CDC indicate that progress has stalled and even reversed in some areas, with malaria incidence showing signs of resurgence.

Several interconnected challenges threaten to undermine hard-won gains:

• Climate change is altering mosquito breeding patterns and expanding transmission zones into previously unaffected areas.
• Poverty and weak health infrastructure limit access to prevention, diagnosis, and treatment services, particularly in rural and conflict-affected regions.
• The emergence of antimalarial drug resistance, including artemisinin partial resistance documented in several African settings, raises serious concerns for the long-term effectiveness of first-line treatments.
• Insecticide resistance in mosquito populations further complicates vector control efforts.
• Substandard health services and coverage gaps hinder timely diagnosis and treatment, increasing the risk of severe disease and death.

the proportion of asymptomatic or clinically atypical malaria cases has increased due to repeated infections and early interventions, complicating diagnosis and increasing the risk of undetected transmission.

The Path Forward: Sustained and Innovative Action

Malaria elimination by 2030 cannot be achieved through aspiration alone. It requires sustained, innovative actions grounded in leadership, implementation quality, accountability, and investment. Africa CDC is partnering with organizations like Medicines for Malaria Venture (MMV) to promote access to quality-assured antimalarial drugs and strengthen health systems.

Key strategies for accelerating progress include:

• Scaling up proven interventions while adapting to changing epidemiological contexts.
• Investing in research and development of new tools, including next-generation vaccines, drugs, and vector control technologies.
• Strengthening surveillance systems to detect and respond to outbreaks and resistance patterns rapidly.
• Ensuring equitable access to interventions for the most vulnerable populations, including children under five and pregnant women.
• Fostering regional cooperation and cross-border initiatives to address the transboundary nature of malaria transmission.
• Securing sustainable financing through domestic resource mobilization and continued international support.

The rollout of malaria vaccines across Africa represents a significant advancement in the fight against the disease. However, vaccine introduction must be integrated into comprehensive malaria control programs rather than viewed as a standalone solution.

Conclusion

The fight against malaria in Africa is at a pivotal moment. While the tools and knowledge to defeat malaria exist, success depends on translating political commitment into effective action on the ground. The resurgence of malaria cases and the emergence of drug resistance serve as urgent reminders that complacency is not an option.

By prioritizing malaria elimination as a cornerstone of health security and sovereignty, African nations can protect their most vulnerable citizens, strengthen health systems, and unlock the continent’s full development potential. The path to a malaria-free Africa by 2030 demands unwavering commitment, innovative strategies, and collective action from governments, health workers, communities, and global partners.

World Malaria Day 2026 serves as both a reminder of the work still ahead and an opportunity to renew the commitment to ending this preventable disease once and for all.